WC
ALNY icon

Wexford Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Wexford Capital’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,250
Closed -$491K – 114
2019
Q1 		$491K Sell
5,250
-5,000
-49% -$418K 0.04% 80
2018
Q4 		$747K Sell
10,250
-6,000
-37% -$461K 0.06% 59
2018
Q3 		$1.42M Hold
16,250
– – 0.09% 95
2018
Q2 		$1.6M Hold
16,250
– – 0.1% 76
2018
Q1 		$1.94M Buy
+16,250
New +$2.09M 0.14% 59
2017
Q3 		– Sell
-4,300
Closed -$343K – 144
2017
Q2 		$343K Buy
+4,300
New +$275K 0.03% 144

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return